Market Overview:
The global salbutamol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of respiratory diseases, increasing awareness about asthma and its treatment, and growing demand for aerosol-based products. Based on type, the global salbutamol market is segmented into solution, aerosol, aerosol spray, and inhalant. Solution dominates the market with a share of more than 60%. This can be attributed to its easy availability and low cost as compared to other forms of salbutamol products. Aerosols are expected to grow at a higher CAGR during the forecast period owing to their benefits such as portability and ease of use. Inhalants are used for emergency relief in cases of acute bronchospasm or anaphylaxis attack and held a small share in 2017; however, this segment is projected to witness high growth during the forecast period owing increased adoption by patients suffering from chronic obstructive pulmonary disease (COPD) across regions.
Product Definition:
Salbutamol (albuterol) is a bronchodilator that relaxes muscles in the airways and increases air flow to the lungs. Salbutamol is used to treat asthma, bronchitis, and other lung diseases. It is also used to prevent exercise-induced asthma.
Solution:
Solution is a combination of excipients and salbutamol. Salbutamol is the main ingredient in Solution. It's used to treat bronchospasm, which occurs due to various reasons such as infection, exercise stress response, genetic factors and drug-induced conditions among others. The other uses include asthma maintenance therapy and prevention of exercise-induced asthmatic symptoms among others.
Aerosol:
Aerosol is a colloidal system of solid or liquid particles suspended in gas. The most common types of aerosols are pressurized metered-dose inhalers (pMDIs), nonpressurized pMDIs, and nebulizers. Aerosols can be characterized as either water-soluble or oil-soluble based on their chemical properties.
Application Insights:
The human application segment held the largest share of over 99.5% in 2017. The drug is used for the treatment of asthma, bronchospasm, and other respiratory diseases such as allergic rhinitis and sinusitis. However, high cost prevents its use in most of the cases due to financial burden on patients.
Animal application is expected to be one of the fastest-growing segments with a CAGR around 10% from 2018 to 2030 owing to rising demand for salbutamol inhalation powder for animal care and management purposes at farms across China, India, Brazil and Mexico among others countries globally. In addition, increasing R&D activities by various players are likely to result in introduction of new products which will fuel market growth further during future periodicals updates.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing demand for salbutamol from various applications. In addition, growing awareness regarding asthma and COPD among individuals of all age groups will drive the regional market growth over the forecast period.
Asia Pacific is anticipated to witness significant growth during the same period due to rising disposable income, improving healthcare infrastructure and an increase in consumer awareness about available treatment options for COPD.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for salbutamol in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options, which is likely to boost the demand for salbutamol in the near future.
- Technological advancements in inhalers: The technological advancements in inhalers are providing better patient compliance, which is expected to fuel the growth of Salbutamol market during forecast period.
- Rising number of smokers: The number of smokers across the globe continues to rise, leading to an increase in cases of respiratory problems such as asthma and chronic obstructive pulmonary disease (COPD). This will create a high demand for Salbutamol over the forecast period. 5) Expanding population base: The expanding population base across emerging economies offers a large potential market for Salbutamol manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Salbutamol Market Research Report
By Type
Solution, Aerosol, Aerosol, Spray, Inhalant
By Application
Human, Animal
By Companies
Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, 3M Pharmaceuticals Inc, Novex, Apotex, Teva Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Salbutamol Market Report Segments:
The global Salbutamol market is segmented on the basis of:
Types
Solution, Aerosol, Aerosol, Spray, Inhalant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Animal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Armstrong Pharmaceuticals
- GlaxoSmithKline
- 3M Pharmaceuticals Inc
- Novex
- Apotex
- Teva Pharmaceuticals
Highlights of The Salbutamol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution
- Aerosol
- Aerosol, Spray
- Inhalant
- By Application:
- Human
- Animal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Salbutamol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Salbutamol is a medication that helps to increase the amount of oxygen in the blood. It is used to treat asthma and other breathing problems.
Some of the major players in the salbutamol market are Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, 3M Pharmaceuticals Inc, Novex, Apotex, Teva Pharmaceuticals.
The salbutamol market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Salbutamol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Salbutamol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Salbutamol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Salbutamol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Salbutamol Market Size & Forecast, 2020-2028
4.5.1 Salbutamol Market Size and Y-o-Y Growth
4.5.2 Salbutamol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solution
5.2.2 Aerosol
5.2.3 Aerosol
5.2.4 Spray
5.2.5 Inhalant
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human
6.2.2 Animal
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Salbutamol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Salbutamol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solution
9.6.2 Aerosol
9.6.3 Aerosol
9.6.4 Spray
9.6.5 Inhalant
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human
9.10.2 Animal
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solution
10.6.2 Aerosol
10.6.3 Aerosol
10.6.4 Spray
10.6.5 Inhalant
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human
10.10.2 Animal
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solution
11.6.2 Aerosol
11.6.3 Aerosol
11.6.4 Spray
11.6.5 Inhalant
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human
11.10.2 Animal
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solution
12.6.2 Aerosol
12.6.3 Aerosol
12.6.4 Spray
12.6.5 Inhalant
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human
12.10.2 Animal
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solution
13.6.2 Aerosol
13.6.3 Aerosol
13.6.4 Spray
13.6.5 Inhalant
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human
13.10.2 Animal
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Salbutamol Market: Competitive Dashboard
14.2 Global Salbutamol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 Armstrong Pharmaceuticals
14.3.3 GlaxoSmithKline
14.3.4 3M Pharmaceuticals Inc
14.3.5 Novex
14.3.6 Apotex
14.3.7 Teva Pharmaceuticals
